Antitrust Antitrust

Crackdowns continue in China against price violations involving antivirus supplies

By Yonnex Li
  • 23 Mar 2020 02:17
  • 23 Mar 2020 02:17
China's market regulators have continued prioritizing enforcement against price violations involving supplies used to combat the ongoing Covid-19 pandemic, vowing to spare no regulatory efforts to keep prices of daily and medical commodities in check.
The State Administration for Market Regulation, or SAMR, recently unveiled a new batch of price

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Yonnex Li

Chief Correspondent, Greater China

Yonnex has an MA in Journalism from the Chinese University of Hong Kong, after obtaining a BA in Translation at the same university. At MLex, she writes extensively on antitrust developments in the Greater China region, including investigations, court cases and merger control of international transactions. Prior to joining MLex, she worked as a reporter at the English division of the Hong Kong Economic Journal, providing coverage and analysis on China's banking sector, asset management industry as well as currency and financial reforms.

Discover MLex

Stay on top of global regulatory developments

Latest News